Your browser is no longer supported. Please, upgrade your browser.
Settings
MNK Mallinckrodt plc daily Stock Chart
MNK [NYSE]
Mallinckrodt plc
Index- P/E- EPS (ttm)-41.51 Insider Own0.90% Shs Outstand83.80M Perf Week15.65%
Market Cap222.91M Forward P/E0.35 EPS next Y7.56 Insider Trans1.13% Shs Float81.61M Perf Month9.02%
Income-3458.00M PEG- EPS next Q1.98 Inst Own- Short Float55.00% Perf Quarter-60.88%
Sales3.25B P/S0.07 EPS this Y-421.90% Inst Trans-0.20% Short Ratio4.78 Perf Half Y-85.06%
Book/sh36.70 P/B0.07 EPS next Y-10.78% ROA-29.60% Target Price5.34 Perf Year-90.31%
Cash/sh2.88 P/C0.92 EPS next 5Y-9.60% ROE-88.20% 52W Range1.43 - 32.34 Perf YTD-83.16%
Dividend- P/FCF0.30 EPS past 5Y4.35% ROI-36.70% 52W High-91.77% Beta2.47
Dividend %- Quick Ratio0.60 Sales past 5Y14.30% Gross Margin44.70% 52W Low86.01% ATR0.31
Employees3700 Current Ratio0.80 Sales Q/Q-0.30% Oper. Margin- RSI (14)49.04 Volatility11.11% 11.90%
OptionableYes Debt/Eq1.80 EPS Q/Q-115.60% Profit Margin- Rel Volume0.91 Prev Close2.55
ShortableYes LT Debt/Eq1.57 EarningsNov 05 BMO Payout- Avg Volume9.40M Price2.66
Recom3.10 SMA2011.88% SMA50-14.69% SMA200-79.15% Volume8,578,441 Change4.31%
Sep-05-19Reiterated BofA/Merrill Underperform $5 → $1
Sep-05-19Downgrade BMO Capital Markets Outperform → Market Perform
Sep-03-19Reiterated Berenberg Sell $5 → $1
Jun-11-19Initiated Barclays Equal Weight
May-31-19Downgrade Piper Jaffray Overweight → Neutral
May-22-19Downgrade Jefferies Buy → Hold
Mar-20-19Initiated SunTrust Hold
Nov-19-18Upgrade Canaccord Genuity Hold → Buy $34 → $40
Sep-11-18Downgrade Goldman Neutral → Sell
Aug-24-18Reiterated B. Riley FBR Neutral $20 → $37
Aug-08-18Reiterated Stifel Hold $18 → $30
Aug-08-18Downgrade Raymond James Outperform → Mkt Perform
May-09-18Reiterated Barclays Underweight $20 → $12
May-02-18Initiated B. Riley FBR, Inc. Neutral $15
Mar-09-18Reiterated Mizuho Neutral $21 → $16
Feb-02-18Downgrade Barclays Equal Weight → Underweight $23 → $20
Jan-09-18Reiterated Mizuho Neutral $22 → $21
Jan-03-18Initiated Leerink Partners Mkt Perform $26
Nov-08-17Reiterated Canaccord Genuity Buy $38 → $24
Nov-08-17Downgrade Wells Fargo Outperform → Market Perform
Oct-18-19 11:02AM  Is the Options Market Predicting a Spike in Mallinckrodt (MNK) Stock? Zacks
Oct-16-19 11:56AM  Opioid Drug Companies Rally On Hopes of Broader Settlement Benzinga +7.69%
Oct-09-19 06:45AM  Mallinckrodt to Report Earnings Results for Third Quarter 2019 PR Newswire -6.94%
Oct-03-19 11:16AM  J&J Settles Ahead of Multi-District Opioid Trial, Stock Up Zacks +8.64%
Oct-02-19 03:07PM  Why St. Louis stocks are trailing stocks nationally this year American City Business Journals
12:41PM  The Market Tells Opioid Drugmakers to Settle Up Bloomberg
10:16AM  JNJ moves to dodge opioid bullets, but other drug names face uncertainty Yahoo Finance
Oct-01-19 10:13AM  Opioid Makers Gain on View Theyll Use Purdue Deal as Model Bloomberg
08:46AM  Mallinckrodt Up on Settlement Agreement With Ohio Counties Zacks
06:45AM  Mallinckrodt Announces Positive Top-Line Findings from its Observational Registry Assessing Relapse Recovery in Multiple Sclerosis Relapse Patients Treated with Acthar® Gel (Repository Corticotropin Injection) PR Newswire
Sep-30-19 08:43PM  Drugmakers look to use Purdue Pharma's bankruptcy to settle U.S. opioid suits: WSJ Reuters +7.11%
08:38PM  UPDATE 1-Drugmakers look to use Purdue Pharma's bankruptcy to settle U.S. opioid suits -WSJ Reuters
10:48AM  Blackstone, Mallinckrodt, Amazon, Walmart: Companies to watch Yahoo Finance
10:38AM  Mallinckrodt Stock Is Rising on Opioid Settlement Barrons.com
10:21AM  Companies to Watch: Blackstone looks to expand, Mallinckrodt reaches settlement in opioid crisis, record weekend for Amazon and Walmart Yahoo Finance Video
09:13AM  US STOCKS-Wall Street poised for higher open as tech stocks rise Reuters
09:08AM  Mallinckrodt stock surges after agreement to pay $24 million to Ohio counties as part of opioid litigation settlement MarketWatch
06:49AM  Mallinckrodt Finalizes Settlement to Resolve "Track 1" Opioid Cases with the Ohio Counties of Cuyahoga and Summit PR Newswire
Sep-25-19 11:25AM  Lone Mallinckrodt Bull Undaunted After Share Price Tumbles 94% Bloomberg
Sep-24-19 02:40PM  5 Stocks That Could Get Crushed By Opioid Lawsuit Tidal Wave Investopedia
02:30PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MMM, MNK and IFF ACCESSWIRE
01:17PM  MALLINCKRODT DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm Newsfile
10:50AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MNK, IFF and VAL ACCESSWIRE
08:48AM  Mallinckrodt's StrataGraft Tissue Phase III Data Positive Zacks
08:47AM  TUESDAY DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Sep-23-19 04:30PM  SHAREHOLDER ALERT: MNK FTCH VRAY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:19PM  Mallinckrodt News: MNK Reports Positive Burn Treatment Results InvestorPlace
03:00PM  SHAREHOLDER ALERT - Mallinckrodt plc (MNK) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: September 24, 2019 GlobeNewswire
10:23AM  Mallinckrodt Shares Rebound On Positive Late-Stage StrataGraft Results Benzinga
10:14AM  Mallinckrodt Stock Is Soaring Because Its News Is Good Enough to Forget Opioids for a Day Barrons.com
09:27AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LB, MNK, JE and PS GlobeNewswire
09:15AM  TUESDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
06:59AM  Mallinckrodt's stock soars after last-stage trial of StrataGraft tissues meets key targets MarketWatch
06:45AM  Mallinckrodt Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of StrataGraft® Regenerative Tissue in Patients with Deep Partial-thickness Thermal Burns PR Newswire
05:30AM  Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results TheStreet.com
Sep-21-19 10:00AM  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Mallinckrodt Plc (NYSE: MNK) and Encourages Mallinckrodt Investors to Contact the Firm Business Wire
Sep-20-19 10:50PM  The Opioid Crisis Hits Home for Investors Barrons.com
03:30PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MNK, EVH and VAL ACCESSWIRE
11:30AM  GLOBALLY RECOGNIZED ROSEN LAW FIRM Reminds Mallinckrodt plc Investors of Important Deadline in Securities Class Action MNK GlobeNewswire
11:00AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MNK, NTAP and VAL ACCESSWIRE
10:20AM  DEADLINE ALERT - Mallinckrodt plc (MNK) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: September 24, 2019 ACCESSWIRE
06:45AM  Mallinckrodt to Present at Cantor Global Healthcare Conference PR Newswire
Sep-19-19 02:35PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MNK, VAL and SRPT ACCESSWIRE
01:16PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline MNK GlobeNewswire
11:19AM  CLASS ACTION UPDATE for NFLX, MNK and OLLI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:15AM  MNK DEADLINE: Pawar Law Group Reminds Investors of September 24 Deadline in Securities Class Action Lawsuit Against Mallinckrodt plc - MNK ACCESSWIRE
10:00AM  FINAL DEADLINE ALERT - Mallinckrodt plc (MNK) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: September 24, 2019 PR Newswire
Sep-18-19 08:55PM  SHAREHOLDER ALERT: KPTI NGHC MNK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE -6.64%
08:14PM  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Mallinckrodt Plc (NYSE: MNK) and Encourages Mallinckrodt Investors to Contact the Firm PR Newswire
11:00AM  CLASS ACTION UPDATE for MMM, NGHC and MNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:20AM  UPCOMING DEADLINE ALERT - Mallinckrodt plc (MNK) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: September 24, 2019 ACCESSWIRE
Sep-17-19 03:15PM  CLASS ACTION UPDATE for MNK, NTAP and VAL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE -9.97%
01:30PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc GlobeNewswire
12:30PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MNK, SRPT and MDP ACCESSWIRE
12:15PM  Implied Volatility Surging for Mallinckrodt (MNK) Stock Options Zacks
10:30AM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc GlobeNewswire
10:02AM  CLASS ACTION UPDATE for MNK, CAH, GVA and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
08:25AM  7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Sep-16-19 03:14PM  OxyContin maker Purdue Pharma files for bankruptcy Yahoo Finance Video -8.79%
01:45PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of LB, MNK and ABMD ACCESSWIRE
10:55AM  INVESTOR ALERT - Mallinckrodt plc (MNK) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: September 24, 2019 ACCESSWIRE
10:45AM  CLASS ACTION UPDATE for NFLX, MNK and ABMD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:15AM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm GlobeNewswire
Sep-13-19 04:30PM  SHAREHOLDER ALERT: VNTR KPTI MNK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE +10.37%
03:15PM  Zhang Investor Law Reminds Investors of Sept. 24 Deadline in Securities Class Action Lawsuit Against Mallinckrodt plc - MNK ACCESSWIRE
03:00PM  Class Action Update - NFLX, KPTI & MNK - Bronstein, Gewirtz & Grossman, LLC GlobeNewswire
10:50AM  SHAREHOLDER ALERT: LB MNK ABMD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:22AM  Class Action Alert - NFLX, KPTI & MNK - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
06:45AM  Mallinckrodt Analysis Suggests Acthar® Gel (Repository Corticotropin Injection) May be a Cost-Effective Option Compared to Other Late-Line, Adult Treatments for Multiple Sclerosis Relapse PR Newswire
Sep-12-19 06:40PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPTI, EGBN and MNK ACCESSWIRE -11.01%
05:50PM  ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Mallinckrodt plc Investors of Important Deadline in Securities Class Action MNK GlobeNewswire
02:30PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MMM, EGBN and MNK ACCESSWIRE
02:07PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline MNK GlobeNewswire
Sep-11-19 04:21PM  Purdue Is Inching Closer to Bankruptcy. Why Opioid Stocks Dont Care. Barrons.com -13.40%
03:12PM  Mallinckrodt's stock falls, as credit downgrade takes some shine off recent surge MarketWatch
01:16PM  A Look At Benzinga Pro's Most-Searched Tickers For September 11, 2019 Benzinga
12:13PM  Mallinckrodt to Divest Contract Manufacturing Unit, Stock Up Zacks
11:00AM  SHAREHOLDER ALERT: NFLX NGHC MNK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:21AM  Class Action Update - NFLX, KPTI & MNK - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
09:02AM  Mallinckrodt Stock Price Nearly Doubles, but Is Still Near Historic Lows Barrons.com
08:02AM  GameStop Stock Plunges, Mallinckrodt Soars on a Calm Morning for the Dow Barrons.com
Sep-10-19 08:05PM  CLASS ACTION UPDATE for NGHC, MNK and GTT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE +84.76%
07:30PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against National General, Mallinckrodt, Oasmia Pharmaceutical, and Aclaris Therapeutics and Encourages Investors to Contact the Firm GlobeNewswire
03:30PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VNTR, NFLX and MNK ACCESSWIRE
02:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK ACCESSWIRE
01:41PM  Mallinckrodt to sell Canadian drug manufacturing unit for $250M American City Business Journals
12:35PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MNK, GVA and NTAP ACCESSWIRE
11:28AM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm GlobeNewswire
09:30AM  Pawar Law Group Reminds Investors of Deadline in Securities Class Action Lawsuit Against Mallinckrodt plc - MNK ACCESSWIRE
08:12AM  Mallinckrodt to sell BioVectra business for $250 million, stock surges MarketWatch
08:09AM  UPDATE 2-Mallinckrodt sells unit for up to $250 mln, sees path forward to settle opioid lawsuits Reuters
07:58AM  Mallinckrodt To Sell BioVectra To HIG Capital For $250M Benzinga
07:08AM  [video]Mallinckrodt to Sell BioVectra Unit to H.I.G. Capital for $250 Million TheStreet.com
07:02AM  Mallinckrodt to sell unit BioVectra for up to $250 mln Reuters
06:45AM  Mallinckrodt Agrees to Sell BioVectra Inc. to H.I.G. Capital for $250 Million PR Newswire
Sep-09-19 05:28PM  Mallinckrodt (MNK) to Resolve Opioid Cases with Ohio Counties Zacks +12.30%
11:00AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MNK, GTT and GVA ACCESSWIRE
10:20AM  UPCOMING DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
10:20AM  Class Action Reminder - NFLX, KPTI & MNK - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Sep-08-19 10:39AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of RLGY, MNK and GTT ACCESSWIRE
Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and gastrointestinal products. It offers H.P. Acthar Gel, an injectable drug for rheumatoid arthritis, multiple sclerosis, infantile spasms, systemic lupus erythematosus, polymyositis, and others; Inomax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Ofirmev, an intravenous formulation of acetaminophen for pain management; and Therakos photopheresis, an immunotherapy treatment platform. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; StrataGraft, which is in Phase III and II clinical development for the treatment of burns; Stannsoporfin, a heme oxygenase inhibitor for the treatment of jaundice; Xenon gas for inhalation; MNK-6105 and MNK-6106, an ammonia scavenger for the treatment of hepatic encephalopathy, a neuropsychiatric syndrome associated with hyperammonemia; VTS-270 that is in Phase III development for Niemann-Pick Type C, a neurodegenerative disease; and CPP-1X/sulindac, which is in Phase III development for Familial Adenomatous Polyposis. It markets its branded products to physicians, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with the Washington University School of Medicine and Silence Therapeutics plc. The company was founded in 1867 and is based in Staines-Upon-Thames, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Reasons Bryan M.EVP & CFOJun 07Buy8.965,40048,38317,979Jun 07 04:12 PM
Trudeau MarkPresident and CEOMay 30Buy9.262,00018,528233,254May 31 07:05 AM
Trudeau MarkPresident and CEOMay 09Buy16.331,00016,325231,254May 10 08:06 AM
Trudeau MarkPresident and CEOMar 05Buy22.651,00022,650229,252Mar 06 08:18 AM
Trudeau MarkPresident and CEODec 10Buy20.181,00020,180236,254Dec 11 08:30 AM